Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia最新文献

筛选
英文 中文
Evolution of Salmonella spp. isolated compared to those of Campylobacter spp. in faecal samples for 12 years. 与 12 年来在粪便样本中分离到的弯曲杆菌属相比,沙门氏菌属的演变情况。
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Pub Date : 2024-10-01 Epub Date: 2024-07-08 DOI: 10.37201/req/038.2024
A de Malet Pintos-Fonseca, S Orol Maseda, I Lopez Lopez, R Rodil Ferreiro, C Ruiz de Alegría Puig, P Alonso Garcia
{"title":"Evolution of Salmonella spp. isolated compared to those of Campylobacter spp. in faecal samples for 12 years.","authors":"A de Malet Pintos-Fonseca, S Orol Maseda, I Lopez Lopez, R Rodil Ferreiro, C Ruiz de Alegría Puig, P Alonso Garcia","doi":"10.37201/req/038.2024","DOIUrl":"10.37201/req/038.2024","url":null,"abstract":"<p><strong>Objective: </strong>The Autonomous Community of Galicia has adopted DECREE 216/2011 on health standards for poultry production, in addition to the Spanish national programs. However, no program has yet been implemented to eradicate campylobacteriosis, which shares the same reservoir. The aim of this study was to compare the evolution of Salmonella spp. isolates with respect to those of Campylobacter spp. in faecal samples received by the Microbiology Department.</p><p><strong>Methods: </strong>A retrospective descriptive comparative study was conducted through the Laboratory Information System (SIL) of Salmonella spp. isolated against Campylobacter spp. in faeces between 2011 and 2022 at the Lucus Augusti University Hospital (HULA), Lugo, Spain.</p><p><strong>Results: </strong>A total of 35,704 stool samples were analysed, of which 3,045 were positive. 751 Salmonella spp. were isolated. Statistical differences were observed in the annual distribution (p<0.01), with a clear turning point in 2018. Five hundred and five patients required hospital care, especially in 2014 with 72 patients (69%). On the other hand, 1,587 Campylobacter spp. were isolated. Required hospital care 1,002 patients during the study, with a peak in 2019 with 111 cases (62%).</p><p><strong>Conclusions: </strong>The reduction of salmonellosis cases and the maintenance of campylobacteriosis cases are directly related to the implementation of DECREE 216/2011. This, in turn, has reduced the pressure on hospitals in the HULA health area. Therefore, we believe that the ONE Health concept is being strengthened in the area studied.</p>","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"409-414"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462323/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141556311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of noninvasive measurement of the indocyanine green plasma disappearance rate in patients with septic shock. 在脓毒性休克患者中使用无创吲哚菁绿血浆消失率测量法。
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Pub Date : 2024-10-01 Epub Date: 2024-06-28 DOI: 10.37201/req/029.2024
I Gutiérrez-Morales, A Loza-Vázquez, J A Sánchez-Román, A Grilo-Reina, M A Navarro-Puerto
{"title":"Use of noninvasive measurement of the indocyanine green plasma disappearance rate in patients with septic shock.","authors":"I Gutiérrez-Morales, A Loza-Vázquez, J A Sánchez-Román, A Grilo-Reina, M A Navarro-Puerto","doi":"10.37201/req/029.2024","DOIUrl":"10.37201/req/029.2024","url":null,"abstract":"<p><strong>Objective: </strong>Our aim was to analyse the relation between serial values of the indocyanine green plasma disappearance rate (ICG-PDR) with hospital mortality in the first 48 hours of ICU admission in patients with septic shock.</p><p><strong>Methods: </strong>A prospective observational study was carried out over 12 months of patients admitted to the ICU with septic shock. Each patient underwent noninvasive determination of ICG-PDR at 24 and 48 hours with the LiMON® module. Follow-up was performed until hospital discharge or exitus.</p><p><strong>Results: </strong>63 patients. Age 61.1±12.3 years. 60.3% men. SOFA score on admission 8.7±3.3, APACHE II score was 27.9±10.7 points. A total of 44.4% of patients died. The ICG-PDR values in the first 24 hours of ICU admission were lower in nonsurvivors: 10.5 (5.7-13.0)%/min vs. 15.9 (11.4-28.0)%/min, p <0.001. Furthermore, in nonsurvivors, there was no improvement in ICG-PDR between 24 h and 48 h, while in survivors, there was an increase of 25%: 15.9 (11.4-28.0)%/min and 20.9 (18.0-27.0)%/min, p=0.020. The silhouette measure of ICG-PDR cohesion and separation for the clusters analysed (nonsurvivors and survivors) was satisfactory (0.6). ICG-PDR<11.7%/min was related to in-hospital mortality, ICG-PDR> 18%/min to survival, and the interval between 11.7% and 18%/min covered a range of uncertainty. In the two-stage cluster, ICG-PDR, SOFA and APACHE II present satisfactory predictive scores 24 hours after patient admission.</p><p><strong>Conclusions: </strong>ICG-PDR in our setting is a useful clinical prognostic tool and could optimise the decision tree in patients with septic shock.</p>","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"401-408"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141461498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mycobacterium abscessus subsp. massilliense causing bartholinitis infection: A case report. 脓肿分枝杆菌亚种(Mycobacterium abscessus subsp. Massilliense)引起的巴氏腺炎感染:病例报告
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Pub Date : 2024-10-01 Epub Date: 2024-06-27 DOI: 10.37201/req/011.2024
A Maldonado-Barrueco, D Grandioso-Vas, M Ruiz-Bastián, J Cacho-Calvo, C Toro, I Quiles-Melero
{"title":"Mycobacterium abscessus subsp. massilliense causing bartholinitis infection: A case report.","authors":"A Maldonado-Barrueco, D Grandioso-Vas, M Ruiz-Bastián, J Cacho-Calvo, C Toro, I Quiles-Melero","doi":"10.37201/req/011.2024","DOIUrl":"10.37201/req/011.2024","url":null,"abstract":"","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"422-424"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141461497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[False negative result in both multiplex and monoplex PCR in a case of Neisseria meningitidis bacteremia. Diagnostic, therapeutic and epidemiological implications]. [在一例脑膜炎奈瑟菌菌血症病例中,多重和单倍聚合酶链反应均出现假阴性结果。诊断、治疗和流行病学意义]。
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Pub Date : 2024-10-01 Epub Date: 2024-07-10 DOI: 10.37201/req/040.2024
M L Monforte, R Cebollada, M J Escobar, R Abad, C Aspiroz
{"title":"[False negative result in both multiplex and monoplex PCR in a case of Neisseria meningitidis bacteremia. Diagnostic, therapeutic and epidemiological implications].","authors":"M L Monforte, R Cebollada, M J Escobar, R Abad, C Aspiroz","doi":"10.37201/req/040.2024","DOIUrl":"10.37201/req/040.2024","url":null,"abstract":"","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"427-428"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141565471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractory Enterobius vermicularis infection in an elderly woman: Mebendazole or albendazole? 一名老年妇女的难治性蚯蚓肠杆菌感染:甲苯咪唑还是阿苯达唑?
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Pub Date : 2024-10-01 Epub Date: 2024-07-12 DOI: 10.37201/req/047.2024
C Carranza-Rodríguez, T Tosco-Nuñez, N Jaén-Sánchez, J Suárez-Hormiga, J L Pérez-Arellano
{"title":"Refractory Enterobius vermicularis infection in an elderly woman: Mebendazole or albendazole?","authors":"C Carranza-Rodríguez, T Tosco-Nuñez, N Jaén-Sánchez, J Suárez-Hormiga, J L Pérez-Arellano","doi":"10.37201/req/047.2024","DOIUrl":"10.37201/req/047.2024","url":null,"abstract":"","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"435-437"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New materials and complications of prostheses in humans: situation in Spain. 人体假体的新材料和并发症:西班牙的情况。
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Pub Date : 2024-10-01 Epub Date: 2024-05-23 DOI: 10.37201/req/039.2024
M Vallet-Regí, A De Alarcón, E Gómez Barrena, J A Planell, J Silva, E Bouza
{"title":"New materials and complications of prostheses in humans: situation in Spain.","authors":"M Vallet-Regí, A De Alarcón, E Gómez Barrena, J A Planell, J Silva, E Bouza","doi":"10.37201/req/039.2024","DOIUrl":"10.37201/req/039.2024","url":null,"abstract":"<p><p>Prostheses or implantable medical devices (IMDs) are parts made of natural or artificial materials intended to replace a body structure and therefore must be well tolerated by living tissues. The types of IMDs currently available and usable are very varied and capable of replacing almost any human organ. A high but imprecise percentage of Spaniards are carriers of one or more IMDs to which they often owe their quality of life or survival. IMDs are constructed with different types of materials that are often combined in the same prosthesis. These materials must combine harmlessness to human tissues with high wear resistance. Their durability depends on many factors both on the host and the type of prosthesis, but the vast majority last for more than 10-15 years or remain in function for the lifetime of the patient. The most frequently implanted IMDs are placed in the heart or great vessels, joints, dental arches or breast and their most frequent complications are classified as non-infectious, particularly loosening or intolerance, and infectious. Complications, when they occur, lead to a significant increase in morbidity, their repair or replacement multiplies the health care cost and, on occasions, can cause the death of the patient. The fight against IMD complications is currently focused on the design of new materials that are more resistant to wear and infection and the use of antimicrobial substances that are released from these materials. Their production requires multidisciplinary technical teams, but also a willingness on the part of industry and health authorities that is not often found in Spain or in most European nations. Scientific production on prostheses and IMD in Spain is estimated to be less than 2% of the world total, and probably below what corresponds to our level of socio-economic development. The future of IMDs involves, among other factors, examining the potential role of Artificial Intelligence in their design, knowledge of tissue regeneration, greater efficiency in preventing infections and taking alternative treatments beyond antimicrobials, such as phage therapy. For these and other reasons, the Ramón Areces Foundation convened a series of experts in different fields related to prostheses and IMDs who answered and discussed a series of questions previously formulated by the Scientific Council. The following lines are the written testimony of these questions and the answers to them.</p>","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"369-386"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141082997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Streptococcus pyogenes vulvovaginitis in adult women]. [成年女性化脓性链球菌外阴阴道炎]。
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Pub Date : 2024-10-01 Epub Date: 2024-07-15 DOI: 10.37201/req/046.2024
C Amores-Antequera, A Delgado-Baena, P Parrado-Hernando, P Cantudo-Muñoz, L Velasco-Rodríguez
{"title":"[Streptococcus pyogenes vulvovaginitis in adult women].","authors":"C Amores-Antequera, A Delgado-Baena, P Parrado-Hernando, P Cantudo-Muñoz, L Velasco-Rodríguez","doi":"10.37201/req/046.2024","DOIUrl":"10.37201/req/046.2024","url":null,"abstract":"","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"432-434"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462322/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141617802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Detection of Epstein-Barr virus in female genital ulcers]. [在女性生殖器溃疡中检测 Epstein-Barr 病毒]。
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Pub Date : 2024-08-01 Epub Date: 2024-05-21 DOI: 10.37201/req/005.2024
J Reina, A Iturbe
{"title":"[Detection of Epstein-Barr virus in female genital ulcers].","authors":"J Reina, A Iturbe","doi":"10.37201/req/005.2024","DOIUrl":"10.37201/req/005.2024","url":null,"abstract":"","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"365-366"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141072307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Early source control of infection in patients seen in the emergency department: a systematic review]. [急诊科病人感染的早期源头控制:系统性回顾]。
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Pub Date : 2024-08-01 Epub Date: 2024-05-14 DOI: 10.37201/req/027.2024
A Julián-Jiménez, R Lorenzo Álvarez, V Gutiérrez Bueno, M Sánchez Trujillo, D Eduardo García
{"title":"[Early source control of infection in patients seen in the emergency department: a systematic review].","authors":"A Julián-Jiménez, R Lorenzo Álvarez, V Gutiérrez Bueno, M Sánchez Trujillo, D Eduardo García","doi":"10.37201/req/027.2024","DOIUrl":"10.37201/req/027.2024","url":null,"abstract":"<p><strong>Objective: </strong>The term source (or focus) control encompasses all those physical measures that can be used to reduce the inoculum and modify those factors in the infectious medium that promote microbial growth or foreign antimicrobial defenses of the host. The main objective of this systematic review (SR) is to know and compare whether early detection and control of the focus (in less than 6 hours) in adult patients treated in the ED for severe infection or sepsis, compared to not controlling the focus or delayed focus control (more than 12 hours) is more effective and safer (improves clinical evolution, mortality, complications, hospital stay or need for ICU admission).</p><p><strong>Methods: </strong>A systematic review is carried out following the PRISMA regulations in the databases of PubMed, Web of Science, EMBASE, Lilacs, Cochrane, Epistemonikos, Tripdatabase and ClinicalTrials.gov from January 2000 to December 31, 2023 without language restrictions and using a combination of MESH terms: \"Source Control\", \"Early\" \"Infection OR Bacterial Infection OR Sepsis\", \"Emergencies OR Emergency OR Emergency Department\" and \"Adults\". Observational cohort studies were included. No meta-analysis techniques were performed, but results were compared narratively.</p><p><strong>Results: </strong>A total of 1,658 articles were identified, of which 2 that met the inclusion criteria and were classified as high quality were finally analyzed. The included studies represent a total of 2,404 patients with 678 cases in which an intervention was performed to control the focus (28.20%). In the first study, 28-day mortality was lower in patients who underwent an intervention to control the focus (12.3% vs. 22.5%; P <0.001), with an adjusted HR of 0.538 (95% CI: 0.389-0.744; P<0.001). In the second, it was demonstrated that the time elapsed from when the patient was evaluated for the first time and was hemodynamically stabilized, until the start of surgery was associated with his survival at 60 days with an OR of 0.31 (95% CI: 0.19-0.45; P <0.0001). In fact, for each hour of delay an adjusted OR of 0.29 (95% CI: 0.16-0.47; P<0.0001) is established. So if the intervention is performed before 2 hours at 60 days, 98% of the patients are still alive, if it is performed between 2-4 hours it is reduced to 78%, if it is between 4-6 hours it drops to 55%, but if it is done for more than 6 hours there will be no survivors at 60 days.</p><p><strong>Conclusions: </strong>This review shows that source control carried out after the evaluation of patients attending the ED reduces short-term mortality (30-60 days) and that it would be advisable to implement any required source control intervention as soon as possible, ideally early (within 6 hours).</p>","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"323-333"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140924206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bacteremia caused by Enterocloster aldenensis in an oncological patient]. [一名肿瘤患者由阿登氏肠球菌引起的菌血症]。
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Pub Date : 2024-08-01 Epub Date: 2024-05-17 DOI: 10.37201/req/025.2024
F Cobo, V Pérez-Carrasco, L Castellano-Sánchez, J A García-Salcedo, J M Navarro-Marí
{"title":"[Bacteremia caused by Enterocloster aldenensis in an oncological patient].","authors":"F Cobo, V Pérez-Carrasco, L Castellano-Sánchez, J A García-Salcedo, J M Navarro-Marí","doi":"10.37201/req/025.2024","DOIUrl":"10.37201/req/025.2024","url":null,"abstract":"","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"367-368"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信